Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

2.53
+0.600031.09%
Post-market: 2.550.0205+0.81%19:59 EDT
Volume:10.33M
Turnover:23.62M
Market Cap:9.11M
PE:-0.07
High:2.77
Open:2.16
Low:1.90
Close:1.93
52wk High:46.50
52wk Low:1.35
Shares:3.60M
Float Shares:3.50M
Volume Ratio:82.44
T/O Rate:295.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-35.2548
EPS(LYR):-37.2229
ROE:-125.89%
ROA:-44.28%
PB:0.44
PE(LYR):-0.07

Loading ...

Company Profile

Company Name:
Co-Diagnostics, Inc.
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
115
Office Location:
2401 S. Foothill Drive,Suite D,Salt Lake City,Utah,United States
Zip Code:
84109
Fax:
- -
Introduction:
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Directors

Name
Position
Dwight Egan
Chief Executive Officer, President and Chairman of the Board
Edward Murphy
Independent Director
Eugene Durenard
Independent Director
James Nelson
Independent Director
Richard Serbin
Independent Director

Shareholders

Name
Position
Dwight Egan
Chief Executive Officer, President and Chairman of the Board
Brian Brown
Chief Financial Officer and Secretary
Richard Abbott
President